Core decompression combined with beta-tricalcium phosphate bioceramics for early non-traumatic osteonecrosis of the femoral head

doi:10.3969/j.issn.2095-4344.2017.06.011

Abstract

Abstract:

BACKGROUND: There are numerous laboratory reports concerning β-tricalcium phosphate (β-TCP)
bioceramics; however, its application in the treatment of osteonecrosis of the femoral head (ONFH) is rarely reported.
OBJECTIVE: To analyze the short-term efficacy of core decompression combined with β-TCP bioceramics in the treatment of ARCO I/II /IIIA non-traumatic ONFH.
METHODS: Twelve patients (16 hips) suffered from ARCO I/II /IIIA non-traumatic ONFH were treated by core decompression combined with β-TCP implantation. The Harris hip scores (HHS) and radiological observation were performed before and after treatment. The HHS at the last follow-up or the HHS prior to the radiographs showing deterioration or severe complication occurrence was recorded.
RESULTS AND CONCLUSION: All patients were followed up for 19 months averagely (11-30 months) and no fracture, infection and other complications occurred. The HHS significantly increased from (73.61±3.70) to (84.88±7.11) points after treatment (P < 0.001). The postoperative outcome was excellent in five cases with five hips, good in five cases with nine hips, mild in one case with one hip, poor in one case with one hip, and the excellent and good rate was 87.5% (14/16). The radiographs of only one case of ARCO IIC and one case of ARCO IIIA showed deterioration, and the latter was given the total hip arthroplasty. These results indicate that the core decompression combined with β-TCP implantation achieve short-term efficacy for ARCO I/II /IIIA non-traumatic ONFH.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

Key words: Femur Head Necrosis, Decompression, Surgical, Calcium Phosphates, Tissue Engineering

CLC Number:

R318

He Sheng-mao, Lin Li-jun, Wang Cheng-qiang, Li Qi. Core decompression combined with beta-tricalcium phosphate bioceramics for early non-traumatic osteonecrosis of the femoral head[J]. Chinese Journal of Tissue Engineering Research, 2017, 21(6): 883-887.

Figures/Tables 2

References

[1]Aaron RK, Voisinet A, Racine J, et al. Corticosteroid-associated avascular necrosis: dose relationships and early diagnosis. Ann N Y Acad Sci. 2011; 1240:38-46.

[2]Kale N, Agaoglu J, Tanik O. Correlation of cumulative corticosteroid treatment with magnetic resonance imaging assessment of avascular femoral head necrosis in patients with multiple sclerosis. Neurol Int. 2010;2(2):e17.

[3]Ollivier M, Lunebourg A, Abdel MP, et al. Anatomical Findings in Patients Undergoing Total Hip Arthroplasty for Idiopathic Femoral Head Osteonecrosis. J Bone Joint Surg Am. 2016; 98(8):672-676.

[4]Floerkemeier T, Thorey F, Daentzer D, et al. Clinical and radiological outcome of the treatment of osteonecrosis of the femoral head using the osteonecrosis intervention implant. Int Orthop. 2011;35(4):489-495.

[5]Kaushik AP, Das A, Cui Q. Osteonecrosis of the femoral head: An update in year 2012. World J Orthop. 2012;3(5):49-57.

[6]胥少汀,葛宝丰,徐印坎.实用骨科学[M].4版.北京:人民军医出版社, 2014:1857-1863.

[7]Mont MA, Zywiel MG, Marker DR, et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010; 92(12):2165-2170.

[8]Kang P, Pei F, Shen B, et al. Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study. Joint Bone Spine. 2012;79(1):67-72.

[9]Yang Z, Liu H, Xie X, et al. Total Hip Arthroplasty for Failed Internal Fixation After Femoral Neck Fracture Versus That for Acute Displaced Femoral Neck Fracture: A Comparative Study. J Arthroplasty. 2015;30(8):1378-1383.

[10]Bednarek A, Atras A, G?ga?a J, et al. Operative technique and results of core decompression and filling with bone grafts in the treatment of osteonecrosis of femoral head. Ortop Traumatol Rehabil. 2010;12(6):511-518.

[11]Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996;(324):169-178.

[12]Scully SP, Aaron RK, Urbaniak JR. Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. J Bone Joint Surg Am. 1998;80(9):1270-1275.

[13]Bobyn JD, Stackpool GJ, Hacking SA, et al. Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg Br. 1999;81(5): 907-914.

[14]Liu ZH, Guo WS, Li ZR, et al. Porous tantalum rods for treating osteonecrosis of the femoral head. Genet Mol Res. 2014;13(4):8342-8352.

[15]Aldegheri R, Taglialavoro G, Berizzi A. The tantalum screw for treating femoral head necrosis: rationale and results. Strategies Trauma Limb Reconstr. 2007;2(2-3):63-68.

[16]Tanzer M, Bobyn JD, Krygier JJ, et al. Histopathologic retrieval analysis of clinically failed porous tantalum osteonecrosis implants. J Bone Joint Surg Am. 2008;90(6): 1282-1289.

[17]Nadeau M, Séguin C, Theodoropoulos JS, et al. Short term clinical outcome of a porous tantalum implant for the treatment of advanced osteonecrosis of the femoral head. Mcgill J Med. 2007;10(1):4-10.

[18]王岩主译.坎贝尔骨科学[M].12版.北京:人民军医出版社,2013: 336.

[19]Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br. 1999;81(2):349-355.

[20]González Della Valle A, Bates J, Di Carlo E, et al. Failure of free vascularized fibular graft for osteonecrosis of the femoral head: a histopathologic study of 6 cases. J Arthroplasty. 2005;20(3):331-336.

[21]Vail TP, Urbaniak JR. Donor-site morbidity with use of vascularized autogenous fibular grafts. J Bone Joint Surg Am. 1996;78(2):204-211.

[22]Stiller M, Kluk E, Bohner M, et al. Performance of β-tricalcium phosphate granules and putty, bone grafting materials after bilateral sinus floor augmentation in humans. Biomaterials. 2014;35(10):3154-3163.

[23]Hing KA, Revell PA, Smith N, et al. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials. 2006;27(29):5014-5026.

[24]Seto S, Muramatsu K, Hashimoto T, et al. A new β-tricalcium phosphate with uniform triple superporous structure as a filling material after curettage of bone tumor. Anticancer Res. 2013;33(11):5075-5081.

[25]Manchón A, Alkhraisat M, Rueda-Rodriguez C, et al. Silicon calcium phosphate ceramic as novel biomaterial to simulate the bone regenerative properties of autologous bone. J Biomed Mater Res A. 2015 Feb;103(2):479-488.

[26]王运涛,郑启新,郭晓东,等. 大鼠骨髓间充质干细胞的优化获取及生物学鉴定[J].华中科技大学学报:医学版, 2003, 32(5): 526-529.

[27]McManus DD, Piacentine SM, Lessard D, et al. Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am J Cardiol. 2011;108(4):477-482.

[28]Takahashi Y, Yamamoto M, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate. Biomaterials. 2005;26(17):3587-3596.

[29]Cheng L, Shi Y, Ye F, et al. Osteoinduction of calcium phosphate biomaterials in small animals. Mater Sci Eng C Mater Biol Appl. 2013;33(3):1254-1260.

[30]Kruse A, Jung RE, Nicholls F, et al. Bone regeneration in the presence of a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute material. Clin Oral Implants Res. 2011;22(5):506-511.

[31]Zerbo IR, Zijderveld SA, de Boer A, et al. Histomorphometry of human sinus floor augmentation using a porous beta-tricalcium phosphate: a prospective study. Clin Oral Implants Res. 2004;15(6):724-732.

[32]Chiba S, Anada T, Suzuki K, et al. Effect of resorption rate and osteoconductivity of biodegradable calcium phosphate materials on the acquisition of natural bone strength in the repaired bone. J Biomed Mater Res A. 2016;104(11): 2833-2842.

[33]Lapczyna H, Galea L, Wüst S, et al. Effect of grain size and microporosity on the in vivo behaviour of β-tricalcium phosphate scaffolds. Eur Cell Mater. 2014;28:299-319.

[34]Dai LY, Jiang LS. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up. Spine (Phila Pa 1976). 2008;33(12):1299-1304.

[35]Veillette CJ, Mehdian H, Schemitsch EH, et al. Survivorship analysis and radiographic outcome following tantalum rod insertion for osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88 Suppl 3:48-55.

[36]Zhao D, Zhang Y, Wang W, et al. Tantalum rod implantation and vascularized iliac grafting for osteonecrosis of the femoral head. Orthopedics. 2013;36(6):789-795.